Evidence map›Paper›PMID 38844871›Full record

ArticlemAbs

Large-scale data mining of four billion human antibody variable regions reveals convergence between therapeutic and natural antibodies that constrains search space for biologics drug discovery.

Pawel Dudzic, Dawid Chomicz, Jarosław Kończak, Tadeusz Satława, Bartosz Janusz, Sonia Wrobel, Tomasz Gawłowski, Igor Jaszczyszyn, Weronika Bielska, Samuel Demharter and 5 more

Abstract read
In one paragraph

Article in mAbs. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Pawel DudzicNaturalAntibody, Szczecin, Poland.
Dawid ChomiczNaturalAntibody, Szczecin, Poland.
Jarosław KończakNaturalAntibody, Szczecin, Poland.
Tadeusz SatławaNaturalAntibody, Szczecin, Poland.
Bartosz JanuszNaturalAntibody, Szczecin, Poland.
Sonia WrobelNaturalAntibody, Szczecin, Poland.
Tomasz GawłowskiNaturalAntibody, Szczecin, Poland.
Igor JaszczyszynNaturalAntibody, Szczecin, Poland.
Weronika BielskaNaturalAntibody, Szczecin, Poland.
Samuel DemharterDiscovery Data Science, Genmab, Copenhagen, Denmark.
Roberto SpreaficoDiscovery Data Science, Genmab, Utrecht, The Netherlands.ORCID 0000-0001-8282-7658
Lukas SchulteGlobal Computational Biology & Digital Sciences, Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach an der Riß, Germany.
Kyle MartinBiotherapeutics Discovery, Boehringer Ingelheim, Ridgefield, CT, USA.
Stephen R ComeauBiotherapeutics Discovery, Boehringer Ingelheim, Ridgefield, CT, USA.
Konrad KrawczykNaturalAntibody, Szczecin, Poland.ORCID 0000-0003-0697-5522

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The naïve human antibody repertoire has theoretical access to an estimated > 10

Indexed as

Biological ProductsComplementarity Determining RegionsData MiningDrug DiscoveryHumansImmunoglobulin Variable RegionBiological ProductsComplementarity Determining RegionsImmunoglobulin Variable RegionCDR-H3databaserepertoire

Identifiers

PMID38844871
PMCPMC11164219

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.